These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9767634)

  • 1. Structure-based design of beta-lactamase inhibitors. 2. Synthesis and evaluation of bridged sulfactams and oxamazins.
    Hubschwerlen C; Angehrn P; Gubernator K; Page MG; Specklin JL
    J Med Chem; 1998 Oct; 41(21):3972-5. PubMed ID: 9767634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams.
    Heinze-Krauss I; Angehrn P; Charnas RL; Gubernator K; Gutknecht EM; Hubschwerlen C; Kania M; Oefner C; Page MG; Sogabe S; Specklin JL; Winkler F
    J Med Chem; 1998 Oct; 41(21):3961-71. PubMed ID: 9767633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of 2 beta-alkenyl penam sulfone acids as inhibitors of beta-lactamases.
    Richter HG; Angehrn P; Hubschwerlen C; Kania M; Page MG; Specklin JL; Winkler FK
    J Med Chem; 1996 Sep; 39(19):3712-22. PubMed ID: 8809160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spirocyclopropyl beta-lactams as mechanism-based inhibitors of serine beta-lactamases. Synthesis by rhodium-catalyzed cyclopropanation of 6-diazopenicillanate sulfone.
    Sandanayaka VP; Prashad AS; Yang Y; Williamson RT; Lin YI; Mansour TS
    J Med Chem; 2003 Jun; 46(13):2569-71. PubMed ID: 12801220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship of 6-methylidene penems bearing tricyclic heterocycles as broad-spectrum beta-lactamase inhibitors: crystallographic structures show unexpected binding of 1,4-thiazepine intermediates.
    Venkatesan AM; Gu Y; Dos Santos O; Abe T; Agarwal A; Yang Y; Petersen PJ; Weiss WJ; Mansour TS; Nukaga M; Hujer AM; Bonomo RA; Knox JR
    J Med Chem; 2004 Dec; 47(26):6556-68. PubMed ID: 15588091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of metallo-beta-lactamase generated from beta-lactam antibiotics.
    Badarau A; Llinás A; Laws AP; Damblon C; Page MI
    Biochemistry; 2005 Jun; 44(24):8578-89. PubMed ID: 15952764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of penam sulfones as inhibitors of beta-lactamases.
    Phillips OA; Reddy AV; Setti EL; Spevak P; Czajkowski DP; Atwal H; Salama S; Micetich RG; Maiti SN
    Bioorg Med Chem; 2005 Apr; 13(8):2847-58. PubMed ID: 15781395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antimicrobial evaluation of 2 beta-chloromethyl-6 beta-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid.
    Gaviraghi G; Perboni A; Tamburini B; Xerri L; Salvatori A; Spadoni G; Tarzia G
    Farmaco; 1996 Jul; 51(7):535-8. PubMed ID: 8765676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamase.
    Li C; Nicolau DP; Lister PD; Quintiliani R; Nightingale CH
    J Antimicrob Chemother; 2004 Feb; 53(2):297-304. PubMed ID: 14729755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase.
    Buzzoni V; Blazquez J; Ferrari S; Calò S; Venturelli A; Costi MP
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3979-83. PubMed ID: 15225711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assays for beta-lactamase activity and inhibition.
    Viswanatha T; Marrone L; Goodfellow V; Dmitrienko GI
    Methods Mol Med; 2008; 142():239-60. PubMed ID: 18437319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semisynthetic beta-lactam antibiotics. 6. 1 Sulfocephalosporins and their antipseudomonal activities.
    Nomura H; Fugono T; Hitaka T; Minami I; Azuma T; Morimoto S; Masuda T
    J Med Chem; 1974 Dec; 17(12):1312-5. PubMed ID: 4214929
    [No Abstract]   [Full Text] [Related]  

  • 14. Nanomolar inhibitors of AmpC beta-lactamase.
    Morandi F; Caselli E; Morandi S; Focia PJ; Blázquez J; Shoichet BK; Prati F
    J Am Chem Soc; 2003 Jan; 125(3):685-95. PubMed ID: 12526668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase.
    Shahid M; Singhai M; Malik A; Shukla I; Khan HM; Shujatullah F; Tahira F
    J Antimicrob Chemother; 2007 Jul; 60(1):187-8. PubMed ID: 17491002
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.
    Bethel CR; Hujer AM; Helfand MS; Bonomo RA
    FEMS Microbiol Lett; 2004 May; 234(1):99-103. PubMed ID: 15109726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A kinetic study on the interaction between tazobactam (a penicillanic acid sulphone derivative) and active-site serine beta-lactamases.
    Perilli M; Franceschini N; Bonfiglio G; Segatore B; Stefani S; Nicoletti G; Perez MM; Bianchi C; Zollo A; Amicosante G
    J Enzyme Inhib; 2000; 15(1):1-10. PubMed ID: 10850951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective trihydroxyazepane NagZ inhibitors increase sensitivity of Pseudomonas aeruginosa to β-lactams.
    Mondon M; Hur S; Vadlamani G; Rodrigues P; Tsybina P; Oliver A; Mark BL; Vocadlo DJ; Blériot Y
    Chem Commun (Camb); 2013 Dec; 49(93):10983-5. PubMed ID: 24136176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activity of beta-lactamase inhibitors combined with beta-lactams against antibiotic-resistant enterobacter.
    Tejedor-Junco MT; Gonzalez-Martin M; Lupiola PA; Santana OE; Lopez-Orge RH; Gonzalez-Lama Z
    J Chemother; 1989 Jul; 1(4 Suppl):346-8. PubMed ID: 16312432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.